Exactly. I do understand arguments to the contrary but I keep coming back to one thought: Mgmt needs to take control of the narrative.

Who has control over the Cytodyn/Leronlimab narrative right now? Shorts and bashers.

I have friends who won’t invest and they’re skeptical of the company and the drug. Why? The share price.